NKT Cell Cytokine Imbalance in Murine Diabetes Mellitus

References

• Bach J.-F. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocrine Rev 1994; 15: 516
   PubMed Web of Science ®Google Scholar
• Delovitch T., Singh B. The Nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 1998; 7: 727
   Google Scholar
• Worrell B.-B., Starkebaum G., Greenbaum C., Palmer J. Peripheral blood mononuclear cells of insulin-dependent diabetic patients respond to multiple islet cell proteins. J. Immunol. 1996; 157: 5668
   Google Scholar
• Charlton B., Laffcrty K. The Thl/Th2 balance in autoimmunity. Cur. Opin. Immunol. 1995; 7: 793
   PubMed Web of Science ®Google Scholar
• Rabinovich A. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM: Therapeutic intervention by immunostimulation. Diabetes 1994; 43: 613
   PubMed Web of Science ®Google Scholar
• Sadick M., Heinzcl F., Holaday B., Pu R., Dawkins R., Locksley R. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon-γ-independent mechanism. J. Exp. Med. 1990; 171: 115
   PubMed Web of Science ®Google Scholar
• Romani L., Mencacci A., Grohmann U., Mocci S., Mosci P., Pucetti P., Bistoni F. Neutralizing antibody to interleukin 4 induces systemic protection and T helper type 1 -associated immunity in murine candidiasis. J. Exp. Med. 1992; 176: 19
   PubMed Web of Science ®Google Scholar
• Chalelain R., Varkila K., Coffman R. IL-4 induces a Th2 response in Leishmania major-infected mice. J. Immunol. 1992; 148: 1182
   Google Scholar
• Backkeskov S., Aanstoot H., Christgau S., Reetz A., Soiimena M., Cascalho M., Folli F., Olesen H., Camilli P. D. Identification of the 64 K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nat 1990; 347: 151
   Google Scholar
• Muir A, Peck A., Salzler M., Song Y.-H., Cornelius J., Luchetta R., Krischcr J., Maclaren N. Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet inter-feron-γ transcription. J. Clin. Invest. 1995; 95: 628
   PubMed Web of Science ®Google Scholar
• Roep B., Kalian A., Hazenbos W., Bruining G., Bailyes E., Arden S., Hutton J., Vrics R. D. T-cell reactivity to 38 kD insulin-secretory-granule protein in patients with recent-onset type 1 diabetes. Lancet 1991; 337: 1439
   PubMed Web of Science ®Google Scholar
• Tisch R., Yang X., Singer S., Liblau R., Fuggcr L., McDevitt H. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nat 1993; 366: 72
   Google Scholar
• Katz J., Wang B., Haskins K., Bcnoist C., Mathis D. Following a diabetogenic T cell from genesis through pathogenesis. Cell 1993; 74: 1089
   PubMed Web of Science ®Google Scholar
• Katz J., Benoist C., Mathis D. T helper cell subsets in insulin-dependent diabetes. Sci 1995; 268: 1185
   PubMed Web of Science ®Google Scholar
• Cambell I., Kay T, Oxbrow L, Harrison L. Essential role for lFN-g and IL-6 in autoimmune insulin-dependent diabetes in NOD/WEH1 mice. J. Clin. Invest. 1991; 87: 739
   Google Scholar
• Rapoport M. J., Jaramillo A., Zipris D., Lazarus A. H., Serreze D. V., Leiter E. H., Cyopick P., Danska J. S., Delovitch T. L. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. Exp. Med. 1993; 178: 87
   PubMed Web of Science ®Google Scholar
• Campbell I., Oxbrow L., Koulmanda M., Harrison L. IFN-g induces islet cell MHC antigens and enhances autoimmune streptozotocin-induccd diabetes in the mouse. J. Immunol. 1988; 140: 1111
   PubMedGoogle Scholar
• Cockfield S., Ramassar V., Urmson J., Halloran P. Multiple low dose streptozotocin induces systemic MHC expression in mice by triggering T cells to release IFN-7. J. Immunol. 1989; 142: 1120
   Google Scholar
• Herold K., Vezys V., Sun Q., Viktora D., Seung E., Reiner S., Brown D. Regulation of cytokine production during development of autoimmune diabetes induced with multiple low doses of streptozotocin. J. Immunol. 1996; 156: 3521
   Google Scholar
• Fox C., Danska J. IL-4 expression at the onset of islet inflammation predicts nondestructive insulitis in nonobese diabetic mice. J. Immunol. 1997; 158: 2414
   PubMed Web of Science ®Google Scholar
• Hsieh C, Heimberger A., Gold J., O'Garra A., Murphy K. Differential regulation of T helper phenotype by Interleukins 4 and 10 in an a/i T cell receptor transgenic system. Proc. Natl. Acad. Sci. 1992; 89: 6065
   PubMed Web of Science ®Google Scholar
• Seder R., Paul W., Davis M., Groth B. F.D.S. The presence of interleukin 4 during in vitro priming determined the lymphokin-producing potential of CD4 + T cells from T cell receptor transgenic mice. J. Exp. Med. 1992; 176: 1091
   PubMed Web of Science ®Google Scholar
• Gross A., Ben-Sasson S., Paul W. Anti-IL-4 diminishes in vivo priming for antigen-specific IL-4 production by T cells. J. Immunol. 1993; 150: 2112
   Google Scholar
• Shehadeh N., LaRosa F., Lafferty K. Altered cytokine activity in adjuvant inhibition of autotimmune diabetes. J. Autoimmunity. 1993; 6: 291
   PubMed Web of Science ®Google Scholar
• Rackc M., Bonomo A., Scott D., Cannclla B., Lcvinc Rainc A., Shevach C. E., Rockcn M. Cylokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 1994; 180, 1961
   Google Scholar
• Arase H., Arase N., Nakagawa K., Good R., Onoc K. NK1.1 CD4+ CD8- thymocytes with specific lympho-kinc secretion. Eur. J. Immunol. 1993; 23: 307
   PubMed Web of Science ®Google Scholar
• Seder R., Paul W. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu. Rev. Immunol. 1994; 12: 635
   PubMed Web of Science ®Google Scholar
• Bendelac A. Mouse NK1.I + cells. Curr. Opin. Immunol. 1995; 7: 367
   PubMed Web of Science ®Google Scholar
• MacDonald H. NK1.1′ T cell receptor-α/β cells: new clues to their origin, specificity and function. J. Exp. Med. 1995; 182: 633
   PubMedGoogle Scholar
• Viacari A., Zlotnik A, Mouse N K. 1.1′ T cells: a new family of T cells. Immunol. Today. 1996; 17: 71
   Google Scholar
• Tanaka T., Kilamura F., Nagasaka Y., Kuida K., Suwa H., Miyasaka M. Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor β chain monoclonal antibody in mice. J. Exp. Med. 1993; 178: 1103
   PubMed Web of Science ®Google Scholar
• Gomberl J.-M., Herbclin A. T., Bohin E., Dy M., Carnaud C., Bach J.-F. Early quantitative and functional deficiency of NK1 -like thymocytes in the NOD mouse. Eur. J. Immunol. 1996; 26: 2989
   Google Scholar
• Lantz O., Bendelac A. An invariant T cell receptor a chain is used by a unique subset of major histocompatibility complex class I-speeific CD4 + and CD4- 8-T cells in mice and humans.,/. Exp. Med. 1994; 180: 1097
   PubMed Web of Science ®Google Scholar
• Bendelac A., Lainz O., Quimby M., Yewdell J., Bennink L., Brutkiewicz R. CD1 recognition by mouse NK I + T lymphocytes. Science 1995; 268: 863
   PubMed Web of Science ®Google Scholar
• Zipris D., Lazarus A., Crow A., Hadzija M., Delovitch T. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. J Immunol 1991; 146: 3763
   PubMed Web of Science ®Google Scholar
• Wood S., Rao T. D., Frey A. B. Multi-dose strepto-zotoein induction of diabetes in BALB/cBy mice induces a T cell receptor-mediated signaling defect in thymocytes which is reversible by interleukin-4 (submitted). 1998
   Google Scholar
• Berman M., Sandborg C, Wang Z., Imfeld K., Zaldivar I'., Dadufalza V., Buckingham B. Decreased IL-4 production in new onset type I insulin-dependent diabetes mcllitus. J. Immunol. 1996; 157: 4690
   PubMed Web of Science ®Google Scholar
• Yoshimolo T, Paul W. CD4Pos NKl.lpos T cells promptly produce Interlcukin 4 in response to vivo challenge with anti-CD3.,J Exp. Med 1994; 179: 1285
   Google Scholar
• Herold K, Vezys V., Sttn Q., Victora D, Seung E, Reiner S., Brown D. Regulation of cytokine production during development of autoimmune diabetes induced with multiple low doses of strcptozotocin. J. Immunol. 1996; 156: 3527
   Google Scholar
• Rabinovitch A., Suarez-Pinzon W., Sorensen O., Bleaekley R., Power R. IE'N-γ gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. J. Immunol. 1995; 154: 4874
   PubMed Web of Science ®Google Scholar
• Matyniak J., Reiner S. T. helper phenotype and genetic susceptibility in experimental Lyme disease. J. Exp. Med. 1995; 181: 1251
   PubMedGoogle Scholar
• Pugh C S, Tabatabai L. Variation in Brucella abortus 2308 infection in BALB/c mice induced by prior vaccination with salt-extractable periplasmic proteins form Brucella abortus 19. Infect. Immun. 1996; 64: 548
   Google Scholar
• Yoshimoto T., Bendelac A., Li H.-J., Paul W. Defective IgE production by SJL mice is linked to the absence of CD4+, NK1.1 + T cells that promptly produce interleukin 4. Proc. Natl. Acad. Sci. 1995; 92: 11931
   PubMed Web of Science ®Google Scholar
• Buschard K., Rygaard J. Passive transfer of strcptozotocin induced diabetes mcllitus with spleen cells. Acta. Path. Microbiol. Scand. Seel. C. 1977; 85: 469
   Google Scholar
• Buschard K., Rygaard J. Is the diabetogenic effect of streptozotocin in part thymus-dependent?. Acta. Path. Microbiol. Scand. Sect. C. 1978; 86: 23
   PubMedGoogle Scholar
• Herold K, Montag A., Fitch F. Treatment with anti-lymphocyte antibodies prevents induction of insulitis in mice given multiple doses of streptozotocin. Diabetes 1987; 36: 796
   PubMedGoogle Scholar
• Herold K. C., Bloch T. N., Vezys V., Sun Q. Diabetes induced with low doses of streptozotocin is mediated by Vβ 8.2 T-cells. Diabetes 1995; 44: 354
   Google Scholar
• Rapoport M. J., Lazarus A. H., Jararmillo A., Speck E., Delovitch T. L. Thymic T cell anergy in autoimmune nonobese diabetic mice is mediated by deficient 1 cell receptor regulation of the the pathway of p21″ activation. J. Exp. Med. 1993; 177: 1221
   PubMed Web of Science ®Google Scholar
• Kishimoto H., Kubo R., Yorifuji H., Nakayama T., Asano Y, Tada T. Physical dissociation of the TCR-CD3 complex accompanies receptor ligation. J. Exp. Med. 1995; 182: 1997
   Google Scholar
• Nishimura T., Santa K., Yuhata T., Sato N., Ohla A, Ohmi Y., Sato T., Hozumi K., Habu S. Involvement of IL-4-producing Vβ8.2′ CD4′ CD62L CD45RB T cells in non-MHC gene-controlled predisposition towards skewing into T helper type-2 immunity in BALB c mice. J. Immunol. 1997; 158: 5698
   PubMedGoogle Scholar
• Weid T. V.D., Beebe A, Roopcnian D, Coffman R. Early production of IL-4 and induction of Th2 responses in the lymph node originate from an M HO class I-independcnt CD4 | NK1.I- T cell population. J. Immunol. 1966; 157: 4421
   Google Scholar
• Brown D., Fowell D., Corry D., Wynn T., Moskowitz N., Cheever A., Locksley R., Reiner S. β2-micro-globulin-dependent NK1.1+ T cells are not essential for T helper cell 2 immune responses. J. Exp. Med. 1996; 184: 1295
   PubMed Web of Science ®Google Scholar
• Smiley S., Kaplan M, Grusby M. Immunoglobulin E production in the absence of I L-4-secreting CD 1-dependent cells. Sci 1997; 275: 977
   PubMedGoogle Scholar
• Wogensen I., Lee M, Sarvctnick N. Production of IL-10 by islet cells accelerates immune-mediated destuetion of beta cells in nonobese diabetic mice. J. Exp. Med. 1994; 179: 1379
   PubMed Web of Science ®Google Scholar
• Pennlinc K., Gaffney R.-E., Monahan M. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin. Immunol. Imtnunopatltol. 1994; 71: 169
   Google Scholar